Doseology Announces CEO Transition
March 31, 2023
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
Silo Wellness Announces Successful Launch of 2022 Psilocybin Retreat Schedule and other Corporate Updates
February 23, 2022
Ryan Allway February 23rd, 2022 Psychedelics, Top News Toronto, Ontario–(Newsfile Corp. – February 23, 2022) – Silo Wellness Inc. (CSE: SILO) (OTCQB: SILFF) (FSE: 3K70) (“Silo Wellness” or the “Company”), a leading global psychedelics company, today announces several corporate updates. On February 4, 2022, the Company completed its first... Read more
atai Life Sciences launches TryptageniX to further expand atai’s robust intellectual property portfolio and strengthen atai’s supply chain
December 9, 2021
Ryan Allway December 9th, 2021 TryptageniX, a majority-owned joint venture with CB Therapeutics, employs bioprospecting to develop new chemical entities with potential applications in mental health. This new platform company will focus on the generation of intellectual property and further strengthen atai’s drug development pipeline of psychedelic and non-psychedelic... Read more
Cognetivity Neurosciences Partners with Ketamine One in Collaborative Clinical Study on Depression and PTSD
December 2, 2021
Ryan Allway December 2nd, 2021 Psychedelics Research study follows deployment of Cognetivity’s ICA in Ketamine One’s North American clinics and will open up novel, tailored use cases in burgeoning mental health market VANCOUVER, BC, Dec. 2, 2021 /CNW/ – Cognetivity Neurosciences Ltd. (the “Company” or “Cognetivity“) (CSE: CGN) (OTCQB: CGNSF) (FWB:... Read more
Blackhawk Growth’s MindBio Therapeutics Brings Digital Mental Health Technology To Psychedelics Clinical Trials
October 7, 2021
Ryan Allway October 7th, 2021 Psychedelics Vancouver, British Columbia – TheNewswire – October 7, 2021 – Blackhawk Growth Corp. (CSE:BLR) (CNSX:BLR.CN) (Frankfurt:0JJ) (the “Company” or “Blackhawk”) is pleased to announce that MindBio Therapeutics is developing a mental health technology platform to integrate with psychedelic treatments in clinical trials in... Read more
This bill would allow Veterans Affairs (VA) doctors to discuss and recommend cannabis as treatment in states where weed is legal and research its effects.
The post Legistation for VA Doctors to Utilize Cannabis appeared first on The Cannifornian.
Read more
Why Psychedelic Delivery Mechanisms Matter
October 2, 2020
Ryan Allway October 2nd, 2020 App, Exclusive, News, Psychedelics, Top News The psychedelics industry is poised to become a nearly $7 billion market by 2027, according to Data Bridge Market Research, driven by the potential to revolutionize the treatment of mental health disorders. While investors have many options in... Read more
MindLeap Health Enters into Fast-Growing Telehealth Market
September 29, 2020
Ryan Allway September 29th, 2020 App, Exclusive, Psychedelics, Top Story The COVID-19 pandemic has led to dramatic changes in healthcare. In addition to mobilizing a vaccine in record time, the pandemic could permanently alter the way that many people seek medical care, shifting from in-person to telehealth. These changes... Read more
Mindleap Health Announces The Launch of The World’s First Telehealth Platform For Psychedelic Integration
September 24, 2020
Ryan Allway September 24th, 2020 Exclusive, Psychedelics, Top News DENVER, Sept. 24, 2020 (GLOBE NEWSWIRE) — Mydecine Innovations Group Inc. (MYCO.CN) (MYCOF) (0NF.F) (“Mydecine” or the “Company”), is pleased to announce that its subsidiary Mindleap Health’s (“Mindleap” ) telehealth platform will be officially available for download from the iOS... Read more
